Micropulse laser for open-angle or pseudoexfoliation glaucoma
Part of Eyes & vision clinical trials.
This study tests a specific eye laser treatment (micropulse) for people with open-angle or pseudoexfoliation glaucoma. It may help lower eye pressure, and the study also checks whether patients can follow the treatment plan and follow-up visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with open-angle glaucoma or pseudoexfoliation glaucoma
- You are 18 years or older
- You can and are willing to follow the study visits and treatment instructions
- You are currently using glaucoma drops as prescribed and can keep doing so
- You do NOT have an allergy to tetracaine or lidocaine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a laser treatment called direct SLT for people with pseudoexfoliation glaucoma. It aims to see if the laser is safe and effective at lowering eye pressure.
This trial compares cataract surgery (phacoemulsification) versus a laser treatment (SLT) as the first treatment for pseudoexfoliation glaucoma. It aims to find which approach lowers eye pressure and helps prevent progression for people with early disease and cataracts.
This study tests a new laser treatment called DSLT for people who have just been diagnosed with open-angle glaucoma or a similar condition like ocular hypertension. It aims to see if the laser can lower eye pressure by at least 20% after six months without needing any eye drops.
This study tests an endoscopic laser procedure to lower eye pressure and slow damage in people with normal-tension glaucoma. It may help protect the optic nerve, especially if your glaucoma is stable on drops and you also have a cataract.
This Phase 3 study tests how best to use a laser treatment (SLT) for people with high eye pressure or mild-to-moderate primary open-angle glaucoma. It aims to find the best way to lower eye pressure and protect vision while comparing treatment approaches.
This trial tests a gentle laser treatment called micropulse laser for diabetic macular edema, a swelling in the back of the eye caused by diabetes. It may help improve vision without the need for injections.
Hear when a new Primary Open Angle Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.